BHA2

Hemoglobin fraction marker

B-Hemoglobin A2

B-Hemoglobin A2 is an important marker in the investigation of hereditary blood diseases such as β-thalassemia. The analysis is part of the Hemoglobin Fractions test and provides valuable information about the hemoglobin composition of the blood.

Hemoglobin fractions
Investigation of sickle cell anemia and sickle cell trait

Hemoglobin fractions

1 490 kr

What is B-Hemoglobin A2?

B-Hemoglobin A2 is one of several hemoglobin types that occur naturally in the blood. It normally constitutes a small proportion – around 2–3.5% – of the total hemoglobin in adults.

Hemoglobin A2 consists of two α-globin chains and two δ-globin chains (α₂δ₂), and is not pathological in itself. However, the level of HbA2 is very valuable as a diagnostic marker, especially when hereditary blood diseases such as β-thalassemia are suspected.

Included in the Hemoglobin Fractions test

The analysis of B-Hemoglobin A2 is one of several subcomponents of the broader B-Hemoglobin Fractions test. This test is used in the investigation of:

  • Thalassemia and other hemoglobinopathies
  • Sickle cell anemia and sickle cell trait
  • Unexplained anemia or microcytosis

Together with analyses of, for example, HbF (fetal hemoglobin) and any deviant hemoglobins (e.g. HbS or HbE), the HbA2 value provides an overall picture of the patient's hemoglobin composition.

When is HbA2 analyzed?

The analysis is particularly recommended in the following cases:

  • Suspected thalassemia minor/trait
  • Microcytic anemia with normal iron levels
  • Genetic investigation before pregnancy
  • Elevated HbF or abnormal blood status

Sampling

The sample is taken via a regular blood sample in an EDTA tube (purple cap). The analysis is performed using advanced laboratory technology to separate and quantify different hemoglobin types.

Tests containing the marker B-Hemoglobin A2

Complete blood count

Complete blood count


Hemoglobin fractions
Investigation of sickle cell anemia and sickle cell trait

Hemoglobin fractions

  • First-line analysis for suspected sickle cell anemia or sickle cell trait
  • Can rule out disease with high certainty without the need for DNA analysis
  • The analysis includes HbS, HbA, HbF and HbA2 for broad diagnostics

1 490 kr